en
Scientific article
English

Enoxaparin versus placebo to prevent symptomatic venous thromboembolism in hospitalized older adult medical patients

Published inNEJM evidence, vol. 2, no. 8, EVIDoa2200332
Publication date2023-08
First online date2023-06-27
Abstract

Enoxaparin to Prevent Venous Thromboembolism in Older AdultsThis trial of thromboprophylaxis in medically ill, hospitalized older adults did not demonstrate that enoxaparin reduced the risk of symptomatic VTE after 1 month. Because the trial was prematurely discontinued, larger trials are needed to definitively address this question.

eng
Keywords
  • Aged
  • Humans
  • Anticoagulants
  • Enoxaparin
  • Patients
  • Venous Thromboembolism / drug therapy
Citation (ISO format)
MOTTIER, Dominique et al. Enoxaparin versus placebo to prevent symptomatic venous thromboembolism in hospitalized older adult medical patients. In: NEJM evidence, 2023, vol. 2, n° 8, p. EVIDoa2200332. doi: 10.1056/EVIDoa2200332
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal2766-5526
12views
0downloads

Technical informations

Creation02/21/2024 10:31:05 AM
First validation04/16/2024 8:37:03 AM
Update time04/16/2024 8:37:03 AM
Status update04/16/2024 8:37:03 AM
Last indexation05/06/2024 6:23:51 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack